TSR INC (TSRI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:TSRI • US8728852075

13.38 USD
+0.01 (+0.04%)
At close: Jun 28, 2024
13.3584 USD
-0.02 (-0.16%)
After Hours: 6/21/2024, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, TSRI scores 5 out of 10 in our fundamental rating. TSRI was compared to 88 industry peers in the IT Services industry. While TSRI has a great health rating, its profitability is only average at the moment. TSRI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • TSRI had positive earnings in the past year.
  • TSRI had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: TSRI reported negative net income in multiple years.
  • In multiple years TSRI reported negative operating cash flow during the last 5 years.
TSRI Yearly Net Income VS EBIT VS OCF VS FCFTSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

  • TSRI has a better Return On Assets (7.75%) than 76.83% of its industry peers.
  • TSRI's Return On Equity of 10.80% is fine compared to the rest of the industry. TSRI outperforms 71.95% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.89%, TSRI is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TSRI is significantly below the industry average of 29.07%.
  • The last Return On Invested Capital (7.89%) for TSRI is above the 3 year average (5.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROIC 7.89%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
TSRI Yearly ROA, ROE, ROICTSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

  • TSRI has a Profit Margin (2.15%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of TSRI has grown nicely.
  • TSRI has a Operating Margin (2.34%) which is in line with its industry peers.
  • TSRI's Operating Margin has improved in the last couple of years.
  • The Gross Margin of TSRI (17.57%) is worse than 92.68% of its industry peers.
  • TSRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
TSRI Yearly Profit, Operating, Gross MarginsTSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

9

2. Health

2.1 Basic Checks

  • TSRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TSRI has less shares outstanding
  • TSRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TSRI Yearly Shares OutstandingTSRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
TSRI Yearly Total Debt VS Total AssetsTSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • TSRI has an Altman-Z score of 8.47. This indicates that TSRI is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of TSRI (8.47) is better than 90.24% of its industry peers.
  • There is no outstanding debt for TSRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.47
ROIC/WACC0.77
WACC10.19%
TSRI Yearly LT Debt VS Equity VS FCFTSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that TSRI has no problem at all paying its short term obligations.
  • The Current ratio of TSRI (3.37) is better than 81.71% of its industry peers.
  • A Quick Ratio of 3.37 indicates that TSRI has no problem at all paying its short term obligations.
  • TSRI's Quick ratio of 3.37 is amongst the best of the industry. TSRI outperforms 81.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
TSRI Yearly Current Assets VS Current LiabilitesTSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.48% over the past year.
  • Measured over the past years, TSRI shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
  • The Revenue for TSRI has decreased by -13.51% in the past year. This is quite bad
  • TSRI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.30% yearly.
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TSRI Yearly Revenue VS EstimatesTSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.56, which indicates a correct valuation of TSRI.
  • Based on the Price/Earnings ratio, TSRI is valued a bit cheaper than the industry average as 75.61% of the companies are valued more expensively.
  • TSRI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.25.
Industry RankSector Rank
PE 15.56
Fwd PE N/A
TSRI Price Earnings VS Forward Price EarningsTSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TSRI is valued cheaper than 84.15% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, TSRI is valued cheaper than 84.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 7.99
TSRI Per share dataTSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • TSRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TSR INC

NASDAQ:TSRI (6/28/2024, 8:00:01 PM)

After market: 13.3584 -0.02 (-0.16%)

13.38

+0.01 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-10
Earnings (Next)08-09
Inst Owners6.6%
Inst Owner Change-43.85%
Ins Owners38.36%
Ins Owner Change0%
Market Cap29.03M
Revenue(TTM)88.82M
Net Income(TTM)1.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE N/A
P/S 0.33
P/FCF 13.32
P/OCF 13.32
P/B 1.64
P/tB 1.85
EV/EBITDA 7.99
EPS(TTM)0.86
EY6.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1
FCFY7.51%
OCF(TTM)1
OCFY7.51%
SpS40.93
BVpS8.15
TBVpS7.23
PEG (NY)N/A
PEG (5Y)0.63
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.75%
ROE 10.8%
ROCE 11.4%
ROIC 7.89%
ROICexc 19.04%
ROICexgc 25.92%
OM 2.34%
PM (TTM) 2.15%
GM 17.57%
FCFM 2.46%
ROA(3y)10.96%
ROA(5y)3.33%
ROE(3y)15.7%
ROE(5y)1.83%
ROIC(3y)5.05%
ROIC(5y)N/A
ROICexc(3y)9.78%
ROICexc(5y)N/A
ROICexgc(3y)13.54%
ROICexgc(5y)N/A
ROCE(3y)7.31%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y1.93%
ROICexc growth 3YN/A
ROICexc growth 5Y-3.61%
OM growth 3YN/A
OM growth 5Y13.97%
PM growth 3YN/A
PM growth 5Y16.86%
GM growth 3Y3.5%
GM growth 5Y1.53%
F-Score8
Asset Turnover3.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 114.1%
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 8.47
F-Score8
WACC10.19%
ROIC/WACC0.77
Cap/Depr(3y)40.97%
Cap/Depr(5y)64.58%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.48%
EPS 3YN/A
EPS 5Y24.57%
EPS Q2Q%377.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.51%
Revenue growth 3Y19.72%
Revenue growth 5Y9.3%
Sales Q2Q%-18.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.3%
EBIT growth 3YN/A
EBIT growth 5Y24.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y217.24%
FCF growth 3YN/A
FCF growth 5Y9.41%
OCF growth 1Y229.8%
OCF growth 3YN/A
OCF growth 5Y9.14%

TSR INC / TSRI FAQ

Can you provide the ChartMill fundamental rating for TSR INC?

ChartMill assigns a fundamental rating of 5 / 10 to TSRI.


What is the valuation status of TSR INC (TSRI) stock?

ChartMill assigns a valuation rating of 4 / 10 to TSR INC (TSRI). This can be considered as Fairly Valued.


What is the profitability of TSRI stock?

TSR INC (TSRI) has a profitability rating of 5 / 10.


What is the valuation of TSR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TSR INC (TSRI) is 15.56 and the Price/Book (PB) ratio is 1.64.


How financially healthy is TSR INC?

The financial health rating of TSR INC (TSRI) is 9 / 10.